Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy

Results in Pharma Sciences

Volumn 2, Issue 1 1-5, 2012, Pages 38-45

  Kumar, Raj ^a   Sahu, Saurabh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Controlled release; Oxaliplatin; Pectin; Polymer nanocarrier; SPIONs; Targeted drugdelivery

Indexed keywords

CALCIUM ION; NANOCARRIER; OXALIPLATIN; PECTIN; PLATINUM; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANTIPROLIFERATIVE ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COOLING; CROSS LINKING; CYTOTOXICITY; DIFFUSION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; DRUG STABILITY; DYNAMIC LIGHT SCATTERING; ENERGY DISPERSIVE X RAY ANALYSIS; LIGHT SCATTERING; MAGNETISM; MAGNETOMETRY; MASS SPECTROMETRY; NANOANALYSIS; NANOENCAPSULATION; NANOFABRICATION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUPERCONDUCTING QUANTUM UNIT INTERFERENCE DEVICE MAGNETOMETRY; SUSTAINED DRUG RELEASE; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY; VIBRATION SAMPLE MAGNETOMETRY; WETTABILITY; X RAY ANALYSIS; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84861957139     PISSN: None     EISSN: 22112863     Source Type: Journal    
DOI: 10.1016/j.rinphs.2012.05.001     Document Type: Article

References (47)

1. Akbulut M, D'Addio SM, Gindy ME, Prud'homme RK. Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles. Expert Review of Clinical Pharmacology 2009;2:265-282.
2. Arias JL. Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery system. Molecules (Basel, Switzerland) 2008;13: 2340-2369.
3. Arias JL, López-Viota M, López-Viota J, Delgado AV. Development of iron/ ethylcellulose (core/ shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. International Journal of Pharmaceutics 2009;382: 270-276.
4. Butescu N, Jordan O, Burdet P, Stadelmann P, Petri-Fink A, Hofmann H, et al. Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: Physicochemical and magnetic properties, in vitro and in vivo drug release. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft fur Pharmazeu- tische Verfahrenstechnik eV 2009;72:529-538.
5. Chari RV. Targeted cancer therapy: conferring specificity to cytotoxic drug. Accounts of Chemical Research 2008;41:98-107.
6. Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. Journal of Controlled Release: Official Journal of the Controlled Release Society 2007;119:5-24.
7. Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nature Nanotechnology 2007;2:495-499.
8. Daou TJ, Pourroy G, Bégin CS, Greneche JM, Ulhaq BC, Legaré P, et al. Hydrothermal synthesis of monodisperse magnetite nanoparticles. Chemistry of Materials: A Publication of the American Chemical Society 2006;18: 4399-4404.
9. Das S, Ng KY. Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on release and bead characteristics. Journal of Pharmaceutical Sciences 2010;99:840-860.
10. Dhar S, Gu FX, Langer R, Farokhz OC, Lippard. SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proceedings of the National Academy of Sciences 2008;105: 17356-17361.
11. Edgar, S, Bernd, M, Stefan, P. US Patent Application no. 20060063720. Oxaliplatin solution concentrate. Filed on September 22 2004. Published on; March 23 2006.
12. El Gibaly I. Oral delayed release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. International Journal of Pharmaceutics 2002;232:199-211.
13. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of Controlled Release: Official Journal of the Controlled Release Society 2012;157:168-182.
14. Englyst HN, Hay S, MacFarlane GT. Polysaccharide breakdown by mixed populations of human faecal bacteria. FEMS Microbiology Ecology 1987;95: 163-171.
15. Frei E, Elias A, Wheeler C, Richardson P, Hryniuk W. The relationship between high-dose treatment and combination chemotherapy: the concept of sum- mation dose intensity. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1998;4:2027-2037.
16. Di Francesco AM, Ruggiero A, Riccardi R. Cellular and molecular aspects of drugs of the future: oxaliplatin. Cellular and Molecular Life Sciences: CMLS 2002;59:1914-1927.
17. Fukamachi T, Chiba Y, Wang X, Saito H, Tagawa M, Kobayashi H. Tumor specific low pH environments enhance the cytotoxicity of lovastatin and cantharidin. Cancer Letters 2010;297:182-189
18. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995-4021
19. Ibrahim A, Hirschfeld S, Cohen MH, Griebel DJ, Williams GA, Pazdur R. FDA drug approval summaries: oxaliplatin. The Oncologist 2009;9:8-12.
20. Jain A, Jain SK. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. European Journal of Pharmaceu- tical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 2008;35:404-416.
21. Jain A, Jain SK, Ganesh N, Barve J, Beg AM. Design and development of ligand- appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine: Nanotechnology, Biology and Medicine 2010;6:179-190.
22. Kayal S, Ramanujan RV. Doxorubicin loaded PVA coated iron oxide nanopar- ticles for targeted drug delivery. Materials Science Engineering 2010;30: 484-490.
23. Kim S, Kim JY, Huh KM, Acharya G, Park K. Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel. Journal of Controlled Release: Official Journal of the Controlled Release Society 2008;132:222-229.
24. Kim J-H, Kim Y-S, Park K, Lee S, Nam HY, Min KH, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. Journal of Controlled Release: Official Journal of the Controlled Release Society 2008;127:41-49.
25. Korsmayer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharma- ceutics 1983;1983(15):25-35.
26. Levy MY, Benita S. Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model. International Journal of Pharmaceutics 1990;66:29-37.
27. Liu L, Fishman ML, Kost J, Hicks KB. Pectin-based systems for colon specific drug delivery via oral route. Biomaterials 2003;24:3333-3343.
28. Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Research 1996;56:4694-4701.
29. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a Review. Journal of Controlled Release: Official Journal of the Controlled Release Society 2000;65:271-284.
30. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and appli- cations in chemotherapy. Advanced Drug Delivery Reviews 2011;63:24-46
31. Mikhaylova M, Kim DK, Bobrysheva N, Osmolowsky M, Semenov V, Tsakalakos T, et al. Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir: the ACS Journal of Surfaces and Colloids 2004;20:2472-2477.
32. Ofori-Kwakye K, Fell JT. Biphasic drug release: the permeability of films containing pectin, chitosan and HPMC. International Journal of Pharmaceu- tics 2001;28:139-145 2001.
33. Park JH, Saravanakumar G, Kim K, Kwon IC. Targeted delivery of low molecular drugs using chitosan and its derivatives. Advanced Drug Delivery Reviews 2010;62:28-41.
34. Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine: Nanotechnology, Biol- ogy and Medicine 2012;8:147-166.
35. Peng X-H, Qian X, Mao H, Chen Wang AY, Nie Z, Shin D.M. S. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Interna- tional Journal of Nanomedicine 2008;3:311-321.
36. Qi J, Yao P, He F, Yu C, Huang C. Nanoparticles with dextran/chitosan shell and BSA/chitosan core-doxorubicin loading and delivery. International Journal of Pharmaceutics 2010;393:176-184.
37. Sahu S, Dutta RK. Novel hybrid nanostructured materials of magnetite nanoparticles and pectin. Journal of Magnetism and Magnetic Materials 2011;323:980-987.
38. Sande SA, Sungthongjeen S, Pitaksuteepong T, Somsiri A, Sriamornsak P. Studies on pectins as potential hydrogel matrices for controlled- release drug delivery. Drug Development and Industrial Pharmacy 1999;25:1271-1276.
39. Siepmann J, Peppas NA. Mathematical modelling of controlled drug delivery. Advanced Drug Delivery Reviews 2001;48:139-157.
40. Singh S, Muthu MS. Preparation and characterization of nanoparticles containing a typical antipsychotic agent. Nanomedicine: Nanotechnology, Biology, and Medicine 2007;2:233-240.
41. Skehn P, Storeng R, Scudiero A, Monks J, McMohan D, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer drug screening. Journal of the National Cancer Institute 1990;82:1107.
42. Vichai V, Kirtikara K. Sulforhodamine B. Colorimetric assay for cytotoxicity screening. Nature Protocols 2006;1:1112-1116.
43. Wang Q, Zhang J, Wang A. Preparation and characterization of a novel pH- sensitive chitosan-g-poly (acrylic acid)/ attapulgite/ sodium alginate compo- site hydrogel bead for controlled release of diclofenac sodium. Carbohydrate Polymers 2009;78:731-737.
44. Wong TW, Colombo G, Sonvico F. Pectin matrix as oral drug delivery vehicle for colon cancer treatment. AAPS PharmSciTech 2011;12:201-214.
45. Yu CY, Cao H, Zhang XC, Zhou FZ, Cheng SX, Zhang XZ, et al. Hybrid nanospheres and vesicles based on pectin as drug carriers. Langmuir: the ACS Journal of Surfaces and Colloids 2009;25:11720-11726.
46. Yuan F, Qin X, Zhou D, Xiang Q-Y, Wang M-T, Zhang Z-R, et al. In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft fur Pharma- zeutische Verfahrenstechnik eV 2008;70:770-776.
47. Zhang JL, Srivastava RS, Misra RDK. Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization, and LCST of viable drug-targeting delivery system. Lang- muir: the ACS Journal of Surfaces and Colloids 2007;23:6343-6351